Page 79 - IngresoDr.MtzLanao

Chu H, Yang W, Sun L, Cai S, Yang R, Liang W, Yu H, Liu L (2020). 4D Printing: A Review on Recent
Progresses. Micromachines (Basel)., 11(9): 796.

Chung YH, Beiss V, Fiering SN, Steinmetz NF (2020). COVID-19 Vaccine Frontrunners and Their
Nanotechnology Design. ACS Nano., 14(10): 12522-12537.

Colino CI, Gutiérrez-Millán C, Lanao JM (2018). Nanoparticles for Signaling in Biodiagnosis and
Treatment of Infectious Diseases. Int J Mol Sci., 19(6): 1627-1655.

Colino CI, Lanao JM, Gutiérrez-Millan C (2020). Targeting of Hepatic Macrophages by
Therapeutic Nanoparticles. Front Immunol., 11: 218-235.

Colino CI, Lanao JM, Gutiérrez-Millan C (2021). Recent advances in functionalized nanomaterials
for the diagnosis and treatment of bacterial infections. Mater Sci Eng C. Mater Biol., 121:
111843.

Conceição J, Farto-Vaamonde X, Goyanes A, Adeoye O, Concheiro A, Cabral-Marques H, Sousa
Lobo JM, Alvarez-Lorenzo C (2019). Hydroxypropyl-beta-cyclodextrin-based fast dissolving
carbamazepine printlets prepared by semisolid extrusion 3D printing. Carbohydr Polym., 221:
55-62.

Csaba N, Garcia-Fuentes M, Alonso MJ (2009). Nanoparticles for nasal vaccination. Adv Drug
Deliv Rev., 61(2): 140-57.

Dacoba TG, Olivera A, Torres D, Crecente-Campo J, Alonso MJ (2017). . Modulating the immune
system through nanotechnology. Semin Immunol., 34: 78-102.

Dacoba TG, Ruiz-Gatón L, Benito A, Klein M, Dupin D, Luo M, Menta M, Teijeiro-Osorio D, Loinaz
I, Alonso MJ, Crecente-Campo J (2020). Technological challenges in the preclinical development
of an HIV nanovaccine candidate. Drug Deliv Transl Res., 10(3): 621-634.

Daemmrich H. (2017). Pharmaceutical Manufacturing in America: A Brief History. Pharmacy in
History. 59 (3): 63-72. Published by: American Institute of the History of Pharmacy.

Dahan A, Miller JM, Amidon GL (2009). Prediction of solubility and permeability class
membership: provisional BCS classification of the world's top oral drugs. AAPS J., 11(4): 740-746.

Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani
S, Mozafari MR (2018). Impact of Particle Size and Polydispersity Index on the Clinical
Applications of Lipidic Nanocarrier Systems. Pharmaceutics. 10(2): 57.

Davanço MG, Campos DR, Carvalho PO (2020). In vitro - In vivo correlation in the development
of oral drug formulation: A screenshot of the last two decades. Int J Pharm., 580: 119210.

Davit BM, Kanfer I, Tsang YC, Cardot JM (2016). BCS Biowaivers: Similarities and Differences
Among EMA, FDA, and WHO Requirements. AAPS J., 18(3): 612-618.

Deng L, Liu H, Ma Y, Miao Y, Fu X, Deng Q (2019). Endocytosis mechanism in physiologically-
based pharmacokinetic modeling of nanoparticles. Appl Pharmacol., 384: 114765.

77